| Institution: | 1. AstraZeneca R&D, Innovative Medicines Personalised Healthcare & Biomarkers, Science for Life Laboratory, , Solna, Sweden;2. Former AstraZeneca R&D, Global Safety Assessment, Molecular Toxicology, , S?dert?lje, Sweden;3. Department of Pharmacology, Faculty of Medicine, Addis Ababa University, , Addis Ababa, Ethiopia;4. Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, , Huddinge, Sweden;5. Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, , Addis Ababa, Ethiopia;6. Department of Medicine, Division of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, , Huddinge, Sweden;7. ?strand Laboratory of Work Physiology, Swedish School of Sport and Health Sciences, Karolinska Institutet, , Stockholm, Sweden;8. MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, University of Liverpool, , Liverpool, UK;9. Department of Oncology‐Pathology, Karolinska Institutet, Karolinska University Hospital, , Solna, Sweden;10. School of Pharmacy, University of North Carolina at Chapel Hill, , Chapel Hill, NC, USA;11. AstraZeneca R&D, Drug Safety & Metabolism, , M?lndal, Sweden |
